Two Sigma Investments, LP Rvl Pharmaceuticals PLC Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.21 - $1.81 $78,074 - $116,788
-64,524 Reduced 74.22%
22,413 $30,000
Q1 2022

May 16, 2022
SELL
$1.03 - $2.01 $167,801 - $327,457
-162,914 Reduced 65.2%
86,937 $147,000
Q4 2021

Feb 14, 2022
BUY
$0.98 - $3.06 $244,853 - $764,544
249,851 New
249,851 $270,000
Q2 2020

Aug 14, 2020
SELL
$2.83 - $6.99 $45,846 - $113,238
-16,200 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$3.18 - $7.0 $51,516 - $113,400
16,200 New
16,200 $52,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email